Renalytix Plc Stock Book Value Per Share

RTNXF Stock  USD 0.62  0.00  0.00%   
Renalytix Plc fundamentals help investors to digest information that contributes to Renalytix Plc's financial success or failures. It also enables traders to predict the movement of Renalytix Pink Sheet. The fundamental analysis module provides a way to measure Renalytix Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix Plc pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Renalytix Book Value Per Share Analysis

Renalytix Plc's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Book Value per Share

 = 

Common Equity

Average Shares

More About Book Value Per Share | All Equity Analysis

Current Renalytix Plc Book Value Per Share

    
  0.25 X  
Most of Renalytix Plc's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Competition

In accordance with the recently published financial statements, the book value per share of Renalytix Plc is about 0.252 times. This is 114.82% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The book value per share for all United States stocks is 99.99% higher than that of the company.

Renalytix Book Value Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Renalytix Plc's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Renalytix Plc could also be used in its relative valuation, which is a method of valuing Renalytix Plc by comparing valuation metrics of similar companies.
Renalytix Plc is currently under evaluation in book value per share category among related companies.

Renalytix Fundamentals

About Renalytix Plc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Renalytix Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Renalytix Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Renalytix Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Renalytix Plc operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 51 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Renalytix Plc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Renalytix Plc's short interest history, or implied volatility extrapolated from Renalytix Plc options trading.

Currently Active Assets on Macroaxis

Check out Renalytix Plc Piotroski F Score and Renalytix Plc Altman Z Score analysis.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Renalytix Pink Sheet analysis

When running Renalytix Plc's price analysis, check to measure Renalytix Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix Plc is operating at the current time. Most of Renalytix Plc's value examination focuses on studying past and present price action to predict the probability of Renalytix Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix Plc's price. Additionally, you may evaluate how the addition of Renalytix Plc to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Please note, there is a significant difference between Renalytix Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Renalytix Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.